Learn How We’re Transforming Drug Discovery

At  MGIntelligence, we are committed to revolutionizing the drug discovery process through our innovative services and advanced technologies. Our multifaceted approach combines the latest advancements in generative AI and quantum computing to tackle the most pressing challenges in biopharmaceutical development. Here’s how we are making a difference:

Publication

Accelerating Drug Discovery Targeting Dihydroorotate Dehydrogenase Using Machine Learning and Generative AI Approaches, Computational Biology and Chemistry

118, 2025, 108443, https://doi.org/10.1016/j.compbiolchem.2025.108443

Publications in pipeline

1.     Machine Learning and Generative AI in the Rational Design of DNA Gyrase-Targeted Antibacterials

2.     Decoding Glioblastoma Transcriptomics: A Decision Tree Regression Approach to Predicting RPKM from RNA-Seq Datasets